Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity

International Journal of Cancer

Volumn 124, Issue 2, 2009, Pages 483-489

  Zhou, Xiaojian ^a,b   Zhang, Zhiyuan ^a,b   Yang, Xiao ^a,b   Chen, Wantao ^a,b   Zhang, Ping ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Research Institute of Stomatology   (China)

Author keywords

Chemotherapy; Cisplatin; Cyclin D1; Nuclear factor kB; Oral squamous cell carcinoma

Indexed keywords

CISPLATIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; SHORT HAIRPIN RNA; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELLULAR DISTRIBUTION; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; MOUTH CARCINOMA; NICK END LABELING; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUTH TUMOR; NUCLEOTIDE SEQUENCE; NUDE MOUSE; SEQUENCE HOMOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CISPLATIN; CYCLIN D1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; NF-KAPPA B; RNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 58249094168     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23964     Document Type: Article

References (21)

1. Zhang P, Zhang ZY, Zhou XJ, Qiu WL, Chen FA, Chen WT. Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer 2006;6:224; doi: 10.1186/1471-2407-6-224.
2. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994;79:551-5.
3. Wang CY, Guttridge DC, Mayo MW, Baldwin AS, Jr. NF-kB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol Cell Biol 1999;19:5923-9.
4. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer cell 2003;3:185-97.
5. Biliran H, Jr, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH, Liao JD. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin Cancer Res 2005;11:6075-86.
6. Driscoll B, Buckley S, Barsky L, Weinberg K, Anderson KD, War- burton D. Abrogation of cyclin D1 expression predisposes lung cancer cells to serum deprivation-induced apoptosis. Am J Physiol 1999; 276:L679-87.
7. Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJ. Cheffetz S, Herlyn.M. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinoma. Cancer Res 1999;59:4876-81.
8. Nakashima T, Clayman GL. Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2000;126:957-61.
9. Kornmann M, Arber N, Korc M. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatin. J Clin Invest 1998;101:344-52.
10. Zhou H, Fujigaki Y, Kato A, Miyaji T, Yasuda H, Tsuji T, Yamamoto T, Yonemura K, Hishida A. Inhibition of p21 modifies the response of cortical proximal tubules to cisplatin in rats. Am J Physiol Renal Physiol 2006;291:F225-35.
11. Kornmann M, Danenberg KD, Arber N, Beger HG, Danenberg PV, Korc M. Inhibition of cyclin D1 expression in human pancreatic can-cer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res 1999;59: 3505-11.
12. Henriksson E, Baldetorp B, Borg A, Kjellen E, Akervall J, Wenner- berg J, Wahlberg P. p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck. Acta Oncol 2006;45:300-5.
13. Han EK, Ng SC, Arber N, Begemann M, Weinstein IB. Roles of cyclin D1 and related genes in growth inhibition, senescence and apo- ptosis. Apoptosis 1999;4:213-9.
14. Kranenburg O, van der Eb AJ, Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 1996;15:46-54.
15. Lu YS, Yeh PY, Chuang SE, Gao M, Kuo ML, Cheng AL. Glucocor-ticoids enhance cytotoxicity of cisplatin via suppression of NF-(kappa)B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa. J Endocrinol 2006;188:311-9.
16. Guo J, Verma UN, Gaynor RB, Frenkel EP, Becerra CR. Enhanced chemosensitivity to irrinotecan by RNA interference-mediated down-regulation for the nuclear factor-kappa B p65 subunit. Clin Cancer Res 2004;10:3333-U.
17. Biliran H, Jr, Banerjee S, Thakur A, Sarkar FH, Bolliq A, Ahmed F, Wu J, Sun Y, Liao JD. C-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells. Clin Cancer Res 2007;13:2811-21.
18. Diehl JA, Benzeno S. Cyclin D1 and pancreatic carcinoma: a prolifer-ative agonist and chemotherapeutic antagonist. Clin Cancer Res 2005;11:5665-7.
19. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366:704-7.
20. Wolter F, Akoglu B, Clausnitzer A, Stein J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 2001;131:2197-203.
21. Lundberg AS, Weinberg RA. Functional inactivation of the retino-blastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998;18:753-61.